A total of 163 stool specimens were tested for detection of Clostridium difficile and its toxin by cytotoxicity assay with tissue culture, latex agglutination test, and isolation of the organism. From 33 specimens which were positive for toxin by cytotoxicity, 30 were positive by the latex agglutination test; the organism was isolated from 21. The total number of samples which were positive with the latex agglutination test was 44. The predictive value of a positive latex agglutination result relative to the cytotoxicity test was 68%, and the predictive value of a negative result was 97.5%. The specificity and sensitivity of the latex agglutination test relative to the cytotoxicity assay and the low cost and simple facilities required indicate that the latex agglutination test is a useful procedure for screening for C. difficile toxins, provided that positive latex results are confirmed by cytotoxicity assay.
Clostridium difficile is the causative agent of antibioticassociated pseudomembranous colitis in humans (1, 2, 7, 10) . There are many reports regarding the laboratory diagnosis of C. difficile in stool samples. Some of these methods are based on the detection of C. difficile toxin in stool samples (4, 11, 15, 20) , whereas others include mainly detection and isolation of the organism from the specimens (6, 8, 14, 22, 23) . Detection of C. difficile toxin using tissue culture (3, 4, 7, 8, 11 ) is the diagnostic procedure that correlates best with pseudomembranous colitis. Some investigators have used counterimmunoelectrophoresis or enzyme-linked immunosorbent assay for demonstrating C. difficile toxin in fecal specimens (11, 12, 15, 20) . However, development of a test for more simple and rapid laboratory detection of toxin is desirable. In this communication, we report the use of a rapid method for detection of C. difficile toxin in stool samples.
MATERIALS AND METHODS
Samples. A total of 163 stool samples were obtained from 152 patients in the Foothills Hospital, Calgary, Alberta. All of the patients were suspected of having pseudomembranous colitis. Samples were submitted to the Microbiology and Infectious Diseases Laboratory of the Foothills Hospital for isolation of C. difficile or for toxin testing. Samples were transferred to the laboratory at ambient temperature. Immediately after receipt (normally within 2 h after defecation), the samples were processed for culture and toxin testing.
Culture. Isolation of C. difficile was performed by the method of Koronsky et al. (9) . Approximately 1 g of undiluted stool specimen was emulsified in an equal volume of 50% alcohol by vigorous mixing in a vortex mixer. The mixture was left at room temperature for 10 min. A few drops of the supernatant were cultured on cefoxitin-cycloserine agar plates, which were incubated anaerobically at 37°C. Resulting colonies of C. difficile were subcultured in chopped-meat broth (Oxoid Ltd., Hants, England), and toxin in the culture supernatant was assayed by the cytotoxicity test.
Toxin testing. A portion of each fresh specimen was (5) . Samples (3 ml) of antitoxin were applied, and the column was eluted with 0.02 M phosphate buffer (pH 7.6). The gamma globulin fraction was collected, concentrated to 3 ml in a speed vacuum concentrator (model RH20-12; Savant Instruments, Inc., Hicksville, N.Y.), and dialyzed against phosphate-buffered saline. Coating of latex with gamma globulin was performed by the method of Newman et al. (13) and Severin (18 Purification and absorption of reagents. Toxin A was purified from crude commercial toxin by column chromatography and acetic acid precipitation by the method of Sullivan et al. (17) .
To remove the antibody to toxin A from the commercial antitoxin, 700 p.g of purified toxin A in 0.5 ml was mixed with 0.5 ml of antitoxin containing 3 mg of protein. For control, 0.5 ml of the antitoxin was mixed with 0.5 ml of saline. The mixtures were left at 25°C for 1 h and then centrifuged for 2 min in a microcentrifuge (model 235A; Fisher Scientific Co., Pittsburgh, Pa.) to remove antigen-antibody complexes. Serial twofold dilutions were prepared in glycine buffer and used for coating latex particles.
The commercial antitoxin also was adsorbed with whole cells of a toxigenic strain of C. difficile (ATCC 9689) by the method of Ryan et al. (16) . RESULTS The results are presented in Table 1 . All toxic specimens were neutralized by C. difficile antitoxin.
The sensitivity and specificity of the latex agglutination test relative to those of the cytotoxicity test were 91 and 91.5%, respectively ( There were 11 specimens that were positive by the latex agglutination test, but negative by cytotoxic assay. The discrepant results could either be false-positives or they could reflect enhanced sensitivity of the latex agglutination test. When we adsorbed the antitoxin with purified toxin A, the titer of the antitoxin was reduced by two-to fourfold, but significant activity remained in seven of the eight samples tested. The antibodies that could not be removed by toxin A could be antibodies to toxin B, to other C. difficile antigens, or to both. It is possible that the higher number of apparent false-positive reactions was due to nonspecific reaction between the nonantitoxin antibodies and some other C. difficile antigens. West and Wilkins (21) have reported that the commercial antitoxin contains antibodies against other C. difficile antigens that react with some strains of nontoxigenic C. difficile. However, absorption of the antitoxin with cells of toxigenic strain of C. difjicile did not reduce the titer of cytotoxic strains appreciably. Also, the results were negative when the antitoxin-coated latex particles were tested against the culture supernatants of C. sordellii and C. bifermentans.
Culture results showed greater agreement with the latex agglutination than with cytotoxicity ( The major disagreement between cytotoxicity and latex agglutination was cytotoxicity-negative and latex agglutination-positive results. It is possible that by using a more specific antisera prepared against purified C. difficile toxins, the number of false-positives may be reduced or eliminated, and closer to 100% correlation with the cytotoxicity assay could be obtained. Ryan et al. (16) have adsorbed the commercial antiserum with the whole cells of C. difficile, thus removing the cross-reacting antibodies. Using this adsorbed antiserum, they succeeded in reducing the nonspecific reactions in the counterimmunoelectrophoresis test. In our study, use of preadsorbed antisera to toxigenic strains of C. difficile did not appreciably affect the reactivity of cytotoxicity-positive specimens in latex agglutination test. We are accumulating false-positive specimens which are cytotoxicity-negative to test them with the preadsorbed antisera. We are also in the process of preparing specific antiserum to purified toxin A. It is possible that using these antisera may reduce the number of false-positives in the latex agglutination test.
